We are committed to partnering with academia, biotech and pharmaceutical companies around the world to jointly discover and develop innovative products that will bring meaningful treatments to cancer patients. BeiGene’s combination of a world-class clinical development team and an experienced commercial team in China differentiates us. Our business development team is dedicated to make a positive impact in the fight against cancers.
I have the privilege to lead the talented business development team here at BeiGene as we uncover new, promising cancer treatments. We are each focused on developing those innovative therapies thoughtfully so they can be made accessible to the patients who need them as quickly as possible.
Read more about our exclusive license agreement for sitravatinib in the Asia Pacific Region.
Our Partnership with Celgene
China is an important market for Celgene, and our collaboration with BeiGene positions us exceptionally well to optimize research, manufacturing, and the long-term commercial potential of our portfolio in China.